Halozyme Therapeutics, Inc. $(HALO)$ is currently at $46.88, down $7.08 or 13.12%

--Would be lowest close since June 5, 2024, when it closed at $45.65

--On pace for largest percent decrease since Jan. 13, 2016, when it fell 17.68%

--Currently down four consecutive days; down 23.26% over this period

--Longest losing streak since Oct. 25, 2024, when it fell for five straight trading days

--Worst four day stretch since the four days ending Jan. 19, 2016, when it fell 25.2%

--Down 7.3% month-to-date

--Up 26.84% year-to-date; on pace for best year since 2022, when it rose 41.51%

--Down 27.23% from its all-time closing high of $64.42 on Aug. 28, 2024

--Up 17.41% from 52 weeks ago (Nov. 17, 2023), when it closed at $39.93

--Down 27.23% from its 52-week closing high of $64.42 on Aug. 28, 2024

--Up 39.19% from its 52-week closing low of $33.68 on Feb. 5, 2024

--Traded as low as $45.71; lowest intraday level since June 5, 2024, when it hit $44.38

--Down 15.29% at today's intraday low; largest intraday percent decrease since March 18, 2020, when it fell as much as 15.38%

All data as of 11:42:21 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 15, 2024 11:46 ET (16:46 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.